{"id":894,"date":"2025-03-07T20:44:45","date_gmt":"2025-03-07T20:44:45","guid":{"rendered":"https:\/\/clinical.hightg.vervetrials.com\/?page_id=894"},"modified":"2026-06-02T13:58:54","modified_gmt":"2026-06-02T13:58:54","slug":"pulse-1","status":"publish","type":"page","link":"https:\/\/hightg.vervetrials.com\/fr\/","title":{"rendered":"Pulse-1"},"content":{"rendered":"<main id='bde-main'><section class=\"bde-section-894-256 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-257 bde-columns\"><div class=\"bde-column-894-258 bde-column\">\n  \n  \n\t\n\n\n\n<h1 class=\"bde-heading-894-259 bde-heading\">\nContribuez \u00e0 fa\u00e7onner l'avenir du traitement de l'hypercholest\u00e9rol\u00e9mie\n<\/h1><div class=\"bde-text-894-260 bde-text\">\nParticiper \u00e0 l'\u00e9tude Pulse-1\n<\/div><div class=\"bde-text-894-261 bde-text\">\nL'\u00e9tude Pulse-1 permettra de d\u00e9terminer si une dose unique d'un m\u00e9dicament exp\u00e9rimental, appel\u00e9 VERVE-201, peut r\u00e9duire en toute s\u00e9curit\u00e9 le cholest\u00e9rol \u00e0 lipoprot\u00e9ines de basse densit\u00e9 (LDLC), souvent appel\u00e9 \"mauvais\" cholest\u00e9rol, chez les personnes dont le LDL-C reste trop \u00e9lev\u00e9 m\u00eame apr\u00e8s avoir pris les m\u00e9dicaments actuellement disponibles.<br><br>Si votre taux de LDL-C reste trop \u00e9lev\u00e9, vous pourriez \u00eatre admissible \u00e0 participer \u00e0 l'\u00e9tude Pulse1.\n<\/div><div class=\"bde-button-894-262 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify\" target=\"_self\" data-type=\"url\"  aria-label=\"See if you prequalify for the Pulse-1 study.\" >\n\n    \n        <span class=\"button-atom__text\">Aller \u00e0 la pr\u00e9s\u00e9lection<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div><div class=\"bde-button-894-263 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify-mobile\" target=\"_self\" data-type=\"url\"  aria-label=\"V\u00e9rifiez si vous remplissez les conditions requises pour participer \u00e0 l'\u00e9tude Pulse-1.\" >\n\n    \n        <span class=\"button-atom__text\">Aller \u00e0 la pr\u00e9s\u00e9lection<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div>\n<\/div><div class=\"bde-column-894-264 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-283 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_hero.jpg\" alt=\"\">\n<\/div><\/div><div class=\"bde-div-894-296 bde-div\">\n  \n  \n\t\n\n\n\n<div class=\"bde-rich-text-894-297 bde-rich-text breakdance-rich-text-styles\">\nL\u2019\u00e9tude Pulse-1 recrute \u00e9galement, dans une partie distincte, des personnes pr\u00e9sentant un taux\n\u00e9lev\u00e9 de cholest\u00e9rol li\u00e9 aux lipoprot\u00e9ines de basse densit\u00e9 (C-LDL). Pour en savoir plus sur\ncette partie de l\u2019\u00e9tude pour les personnes ayant un taux \u00e9lev\u00e9 de C-LDL, <a href=\"https:\/\/vervetrials.com\">cliquez ici.<\/a>\n<\/div>\n<\/div><\/div>\n<\/section><nav class=\"bde-section-894-110 bde-section\" aria-label=\"content\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-div-894-111 bde-div\">\n              \n  \n  \n\t\n\n\n\n<div class=\"bde-menu-894-112 bde-menu\">\n\n\n      \n        \n    <nav class=\"breakdance-menu breakdance-menu--collapse\">\n    <button class=\"breakdance-menu-toggle breakdance-menu-toggle--squeeze\" type=\"button\" aria-label=\"Ouvrir le menu\" aria-expanded=\"false\" aria-controls=\"menu-112\">\n                  <span class=\"breakdance-menu-toggle-icon\">\n            <span class=\"breakdance-menu-toggle-lines\"><\/span>\n          <\/span>\n            <\/button>\n    \n  <ul class=\"breakdance-menu-list\" id=\"menu-112\">\n              \n  \n    <li class=\"bde-button-894-113 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-about\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">\u00c0 propos de l\u2019\u00e9tude<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-114 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-why-participate\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">Pourquoi participer?<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-115 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-what-to-expect\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">\u00c0 quoi s'attendre en participant \u00e0 l'\u00e9tude<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-116 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-participant-qualifications\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">Crit\u00e8res d\u2019admissibilit\u00e9 des participants<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-117 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-qualify\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">D\u00e9couvrez si vous vous pr\u00e9qualifiez<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-118 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-details\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">D\u00e9tails de l'\u00e9tude<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li><li class=\"bde-button-894-119 bde-button breakdance-menu-item\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-locations\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">Lieux d\u2019\u00e9tude<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/li>\n  <\/ul>\n  <\/nav>\n\n\n<\/div>\n<\/div><\/div>\n<\/nav><section id=\"pulse-about\" class=\"bde-section-894-120 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-121 bde-columns\"><div class=\"bde-column-894-124 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-284 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_about.jpg\" alt=\"\"><h2 class=\"bde-heading-894-125 bde-heading\">\n\u00c0 propos de l'\u00e9tude Pulse-1\n<\/h2><div class=\"bde-rich-text-894-126 bde-rich-text breakdance-rich-text-styles\">\n<p>L\u2019\u00e9tude Pulse-1 est un essai clinique de phase\u00a01b qui recrute des personnes atteintes\nd\u2019hypertriglyc\u00e9rid\u00e9mie grave. L\u2019\u00e9tude Pulse-1 aidera \u00e0 d\u00e9terminer si une dose unique d\u2019un\nm\u00e9dicament exp\u00e9rimental, appel\u00e9 VERVE-201, peut contribuer \u00e0 r\u00e9duire de fa\u00e7on s\u00e9curitaire et\ndurable le taux de triglyc\u00e9rides chez les personnes dont les taux demeurent \u00e9lev\u00e9s, m\u00eame\napr\u00e8s avoir apport\u00e9 les changements de mode de vie recommand\u00e9s et pris les m\u00e9dicaments\nactuellement disponibles pour abaisser les triglyc\u00e9rides (comme les fibrates, les acides gras\nom\u00e9ga-3 ou la niacine). <br \/><br \/>Jusqu\u2019\u00e0 36\u00a0personnes seront inscrites dans plusieurs pays \u00e0 l\u2019\u00e9tude\u00a0Pulse-1. Les participants\nprendront part \u00e0 l\u2019essai pendant une p\u00e9riode pouvant aller jusqu\u2019\u00e0 un an apr\u00e8s avoir re\u00e7u\nVERVE-201. Une fois l\u2019\u00e9tude termin\u00e9e, les participants devraient prendre part \u00e0 une \u00e9tude de\nsuivi \u00e0 long terme pour aider les chercheurs \u00e0 mieux comprendre l\u2019innocuit\u00e9 de VERVE-201 sur\nune p\u00e9riode prolong\u00e9e. Le m\u00e9decin de l\u2019\u00e9tude vous fournira plus de d\u00e9tails concernant cette\n\u00e9tude.<\/p>\n<\/div>\n<\/div><\/div><div class=\"bde-div-894-127 bde-div\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-128 bde-heading\">\n\u00c0 propos du m\u00e9dicament exp\u00e9rimental\n<\/h2><div class=\"bde-rich-text-894-293 bde-rich-text breakdance-rich-text-styles\">\n<p>VERVE-201, le m\u00e9dicament exp\u00e9rimental d\u2019\u00e9dition g\u00e9nomique, est administr\u00e9 sous forme d\u2019une\nseule perfusion intraveineuse (i.v.) dans une veine du bras. VERVE-201 cible un g\u00e8ne\nsp\u00e9cifique dans le foie, appel\u00e9 ANGPTL3. Ce g\u00e8ne produit la prot\u00e9ine ANGPTL3, dont on sait\nqu\u2019elle augmente le taux de triglyc\u00e9rides dans le sang. Dans certains essais cliniques, les\nm\u00e9dicaments exp\u00e9rimentaux qui bloquent la prot\u00e9ine ANGPTL3 ont \u00e9t\u00e9 associ\u00e9s \u00e0 une\ndiminution du taux de triglyc\u00e9rides. <em>ANGPTL3<\/em>. This gene makes the ANGPTL3 protein that is known to increase triglyceride levels in the blood. In some clinical trials, investigational medications that block the ANGPTL3 protein have been associated with decreases in triglyceride levels.<\/p>\n<\/div><div id=\"brochure-en\" class=\"bde-button-894-130 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"\/wp-content\/uploads\/2025\/02\/Pulse-1_PatientBrochure_Digital_15Jan2025_-V1.0.pdf\" target=\"_self\" data-type=\"url\"  aria-label=\"Download the brochure about the investigational medicine\" >\n\n    \n        <span class=\"button-atom__text\">T\u00e9l\u00e9charger la brochure<\/span>\n\n                            \n        \n                <\/a>\n\n    \n\n\n<\/div>\n<\/div><\/div>\n<\/section><section class=\"bde-section-894-131 bde-section\">\n              \n  \n  \n\t\n\n  <div class=\"section-background-overlay\"><\/div>\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-132 bde-columns\"><div class=\"bde-column-894-133 bde-column\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-134 bde-heading\">\nQue sont les triglyc\u00e9rides et pourquoi sont-ils importants?\n<\/h2><div class=\"bde-text-894-135 bde-text\">\nLes triglyc\u00e9rides sont un type de gras (lipides) que l\u2019on retrouve dans votre sang et qui est\nstock\u00e9 dans les cellules adipeuses. Un taux de triglyc\u00e9rides trop \u00e9lev\u00e9 peut causer une\npancr\u00e9atite et augmenter le risque d\u2019une maladie cardiaque appel\u00e9e maladie cardiovasculaire\nath\u00e9roscl\u00e9reuse (MCVAS). La pancr\u00e9atite est une affection potentiellement grave caract\u00e9ris\u00e9e\npar une inflammation du pancr\u00e9as et n\u00e9cessitant souvent une hospitalisation en raison de\ndouleurs abdominales importantes, de fi\u00e8vre ou de vomissements. La MCVAS est un terme\ng\u00e9n\u00e9ral pour d\u00e9signer des affections caus\u00e9es par l\u2019accumulation de plaques de cholest\u00e9rol\ndans les art\u00e8res. Si l\u2019accumulation de plaque devient importante, elle peut restreindre la\ncirculation sanguine et entra\u00eener des \u00e9v\u00e9nements cardiovasculaires graves, comme une crise\ncardiaque ou un accident vasculaire c\u00e9r\u00e9bral (AVC).<br><br>La r\u00e9duction du taux de triglyc\u00e9rides dans le sang peut diminuer le risque de d\u00e9velopper une\npancr\u00e9atite et contribuer \u00e0 pr\u00e9venir les crises cardiaques et les AVC.<br><br>Chez certaines personnes, le taux de triglyc\u00e9rides demeure sup\u00e9rieur \u00e0 la cible recommand\u00e9e\nsur le plan m\u00e9dical, m\u00eame apr\u00e8s avoir apport\u00e9 des changements \u00e0 leur mode de vie et pris les\nm\u00e9dicaments actuellement disponibles pour r\u00e9duire les triglyc\u00e9rides (comme les fibrates, les\nacides gras om\u00e9ga-3 ou la niacine). Ces personnes pr\u00e9sentent un risque accru de pancr\u00e9atite,\nde crise cardiaque ou d\u2019AVC comparativement aux personnes qui atteignent leur cible.\n<\/div>\n<\/div><div class=\"bde-column-894-136 bde-column\">\n  \n  \n\t\n\n\n\n\n<\/div><\/div><\/div>\n<\/section><section class=\"bde-section-894-266 bde-section\">\n              \n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-267 bde-columns\"><div class=\"bde-column-894-268 bde-column\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-269 bde-heading\">\nQue sont les triglyc\u00e9rides et pourquoi sont-ils importants?\n<\/h2><div class=\"bde-text-894-270 bde-text\">\nLes triglyc\u00e9rides sont un type de gras (lipides) que l\u2019on retrouve dans votre sang et qui est\nstock\u00e9 dans les cellules adipeuses. Un taux de triglyc\u00e9rides trop \u00e9lev\u00e9 peut causer une\npancr\u00e9atite et augmenter le risque d\u2019une maladie cardiaque appel\u00e9e maladie cardiovasculaire\nath\u00e9roscl\u00e9reuse (MCVAS). La pancr\u00e9atite est une affection potentiellement grave caract\u00e9ris\u00e9e\npar une inflammation du pancr\u00e9as et n\u00e9cessitant souvent une hospitalisation en raison de\ndouleurs abdominales importantes, de fi\u00e8vre ou de vomissements. La MCVAS est un terme\ng\u00e9n\u00e9ral pour d\u00e9signer des affections caus\u00e9es par l\u2019accumulation de plaques de cholest\u00e9rol\ndans les art\u00e8res. Si l\u2019accumulation de plaque devient importante, elle peut restreindre la\ncirculation sanguine et entra\u00eener des \u00e9v\u00e9nements cardiovasculaires graves, comme une crise\ncardiaque ou un accident vasculaire c\u00e9r\u00e9bral (AVC).<br><br>La r\u00e9duction du taux de triglyc\u00e9rides dans le sang peut diminuer le risque de d\u00e9velopper une\npancr\u00e9atite et contribuer \u00e0 pr\u00e9venir les crises cardiaques et les AVC.<br><br>Chez certaines personnes, le taux de triglyc\u00e9rides demeure sup\u00e9rieur \u00e0 la cible recommand\u00e9e\nsur le plan m\u00e9dical, m\u00eame apr\u00e8s avoir apport\u00e9 des changements \u00e0 leur mode de vie et pris les\nm\u00e9dicaments actuellement disponibles pour r\u00e9duire les triglyc\u00e9rides (comme les fibrates, les\nacides gras om\u00e9ga-3 ou la niacine). Ces personnes pr\u00e9sentent un risque accru de pancr\u00e9atite,\nde crise cardiaque ou d\u2019AVC comparativement aux personnes qui atteignent leur cible.\n<\/div>\n<\/div><div class=\"bde-column-894-271 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-272 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_block-alt.png\" alt=\"\" srcset=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_block-alt.png 700w, https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_block-alt-300x236.png 300w, https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_block-alt-15x12.png 15w\" sizes=\"(max-width: 700px) 100vw, 700px\">\n<\/div><\/div><\/div>\n<\/section><section id=\"pulse-why-participate\" class=\"bde-section-894-138 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-139 bde-columns\"><div class=\"bde-column-894-140 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-285 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_why.png\" alt=\"\">\n<\/div><div class=\"bde-column-894-142 bde-column\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-143 bde-heading\">\nPourquoi participer?\n<\/h2><div class=\"bde-rich-text-894-144 bde-rich-text breakdance-rich-text-styles\">\n<p>En participant \u00e0 l\u2019\u00e9tude Pulse-1, vous contribuerez au d\u00e9veloppement d\u2019un nouveau\nm\u00e9dicament potentiel qui pourrait vous aider, et aider d\u2019autres personnes pr\u00e9sentant un taux\n\u00e9lev\u00e9 de triglyc\u00e9rides \u00e0 l\u2019avenir. Les participants \u00e0 l\u2019\u00e9tude recevront VERVE-201, ce qui pourrait\naider \u00e0 r\u00e9duire le taux de triglyc\u00e9rides pendant de nombreuses ann\u00e9es, possiblement de fa\u00e7on\npermanente, apr\u00e8s une dose unique. Cependant, il est important de noter que l\u2019innocuit\u00e9 et\nl\u2019efficacit\u00e9 du m\u00e9dicament exp\u00e9rimental sur la r\u00e9duction du taux de triglyc\u00e9rides n\u2019ont pas \u00e9t\u00e9\nd\u00e9montr\u00e9es.<br \/>proven.<\/p>\n<\/div><div class=\"bde-button-894-145 bde-button\">\n        \n    \n    \n    \n              \n            \n                    \n            \n            \n\n    \n    \n    \n    \n              \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">Aller \u00e0 la pr\u00e9s\u00e9lection<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div><div class=\"bde-button-894-146 bde-button\">\n        \n    \n    \n    \n    \n            \n                    \n            \n            \n\n    \n    \n    \n    \n    \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify-mobile\" target=\"_self\" data-type=\"url\"  >\n\n    \n        <span class=\"button-atom__text\">Aller \u00e0 la pr\u00e9s\u00e9lection<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div>\n<\/div><\/div><\/div>\n<\/section><section class=\"bde-section-894-147 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><\/div>\n<\/section><section id=\"pulse-what-to-expect\" class=\"bde-section-894-150 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><h2 class=\"bde-heading-894-151 bde-heading\">\n\u00c0 quoi vous attendre si vous participez \u00e0 l\u2019\u00e9tude Pulse-1\n<\/h2><div class=\"bde-grid-894-152 bde-grid\">\n  \n  \n\t\n\n\n\n<div class=\"bde-div-894-153 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-273 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1-warning.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1-warning.webp 165w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1-warning-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1-warning-12x12.webp 12w\" sizes=\"(max-width: 165px) 100vw, 165px\"><div class=\"bde-text-894-155 bde-text\">\nLe personnel de l\u2019\u00e9tude vous expliquera les avantages et les risques possibles de votre\nparticipation \u00e0 l\u2019\u00e9tude Pulse-1.\n<\/div>\n<\/div><div class=\"bde-div-894-156 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-274 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-1.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-1.webp 165w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-1-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-1-12x12.webp 12w\" sizes=\"(max-width: 165px) 100vw, 165px\"><div class=\"bde-text-894-158 bde-text\">\nSi vous choisissez de participer \u00e0 un essai clinique, vous pourrez cesser d\u2019y participer \u00e0 tout\nmoment.\n<\/div>\n<\/div><div class=\"bde-div-894-159 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-275 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-2.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-2.webp 165w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-2-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-2-12x12.webp 12w\" sizes=\"(max-width: 165px) 100vw, 165px\"><div class=\"bde-text-894-161 bde-text\">\nLes participants pourraient recevoir un remboursement pour leur temps, leurs frais de\nd\u00e9placement et autres d\u00e9penses pendant leur participation \u00e0 cette \u00e9tude.\n<\/div>\n<\/div><div class=\"bde-div-894-165 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-277 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-4-2.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-4-2.webp 164w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-4-2-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-4-2-12x12.webp 12w\" sizes=\"(max-width: 164px) 100vw, 164px\"><div class=\"bde-text-894-167 bde-text\">\nVERVE-201 et les tests li\u00e9s \u00e0 l\u2019\u00e9tude sont fournis sans frais aux participants.\n<\/div>\n<\/div><div class=\"bde-div-894-168 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-278 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-5.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-5.webp 164w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-5-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-5-12x12.webp 12w\" sizes=\"(max-width: 164px) 100vw, 164px\"><div class=\"bde-text-894-170 bde-text\">\nUne \u00e9quipe de m\u00e9decins et d\u2019infirmi\u00e8res suivra votre sant\u00e9 de pr\u00e8s tout au long de l\u2019essai.\n<\/div>\n<\/div><div class=\"bde-div-894-171 bde-div\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-279 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-6.webp\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-6.webp 164w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-6-150x150.webp 150w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/pulse-1_expect-6-12x12.webp 12w\" sizes=\"(max-width: 164px) 100vw, 164px\"><div class=\"bde-text-894-173 bde-text\">\nL\u2019\u00e9tude a \u00e9t\u00e9 approuv\u00e9e par un comit\u00e9 d\u2019examen institutionnel\/comit\u00e9 d\u2019\u00e9thique ainsi que par\nles autorit\u00e9s sanitaires comp\u00e9tentes, ce qui garantit la protection des droits, de la s\u00e9curit\u00e9 et du\nbien-\u00eatre des participants.\n<\/div>\n<\/div>\n<\/div><\/div>\n<\/section><section id=\"pulse-participant-qualifications\" class=\"bde-section-894-174 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-columns-894-175 bde-columns\"><div class=\"bde-column-894-176 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-286 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-1_qualify.png\" alt=\"\">\n<\/div><div class=\"bde-column-894-178 bde-column\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-179 bde-heading\">\nCrit\u00e8res d\u2019admissibilit\u00e9 des participants\n<\/h2><div class=\"bde-text-894-180 bde-text\">\nVous pourriez \u00eatre en mesure de participer si vous*\u00a0:\n<\/div><div class=\"bde-columns-894-181 bde-columns\"><div class=\"bde-column-894-182 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-288 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-icon-blue.png\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-icon-blue.png 53w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-icon-blue-14x12.png 14w\" sizes=\"(max-width: 53px) 100vw, 53px\">\n<\/div><div class=\"bde-column-894-184 bde-column\">\n  \n  \n\t\n\n\n\n<div class=\"bde-text-894-185 bde-text\">\n\u00cates \u00e2g\u00e9(e) de 18 \u00e0 70\u00a0ans\n<\/div>\n<\/div><\/div><div class=\"bde-columns-894-186 bde-columns\"><div class=\"bde-column-894-187 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-289 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-heart-blue.png\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-heart-blue.png 50w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-heart-blue-13x12.png 13w\" sizes=\"(max-width: 50px) 100vw, 50px\">\n<\/div><div class=\"bde-column-894-189 bde-column\">\n  \n  \n\t\n\n\n\n<div class=\"bde-text-894-190 bde-text\">\nAvez des ant\u00e9c\u00e9dents m\u00e9dicaux de taux de triglyc\u00e9rides tr\u00e8s \u00e9lev\u00e9s, c.-\u00e0-d.\nd\u2019hypertriglyc\u00e9rid\u00e9mie grave\n<\/div>\n<\/div><\/div><div class=\"bde-columns-894-194 bde-columns\"><div class=\"bde-column-894-195 bde-column\">\n  \n  \n\t\n\n\n\n<img decoding=\"async\" class=\"bde-image2-894-290 bde-image2\" src=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-blood-blue.png\" alt=\"\" srcset=\"https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-blood-blue.png 48w, https:\/\/hightg.vervetrials.com\/wp-content\/uploads\/sites\/25\/2026\/03\/qualifications-blood-blue-11x12.png 11w\" sizes=\"(max-width: 48px) 100vw, 48px\">\n<\/div><div class=\"bde-column-894-197 bde-column\">\n  \n  \n\t\n\n\n\n<div class=\"bde-text-894-198 bde-text\">\nPr\u00e9sentez un taux de triglyc\u00e9rides qui demeure trop \u00e9lev\u00e9, m\u00eame apr\u00e8s avoir\nadopt\u00e9 les changements de mode de vie recommand\u00e9s et pris les m\u00e9dicaments\ndisponibles pour r\u00e9duire les triglyc\u00e9rides\n<\/div><div class=\"bde-text-894-199 bde-text\">\n(comme les fibrates, les acides gras\nom\u00e9ga-3 ou la niacine).\n<\/div><div class=\"bde-text-894-200 bde-text\">\nDans certains cas, des personnes ne peuvent pas\nprendre ces m\u00e9dicaments en raison d\u2019effets secondaires, parce qu\u2019ils ne sont\npas recommand\u00e9s par leurs professionnels de la sant\u00e9 ou parce qu\u2019ils n\u2019y ont\npas acc\u00e8s. Si c\u2019est votre cas, vous pourriez tout de m\u00eame \u00eatre admissible.\n<\/div><div class=\"bde-text-894-201 bde-text\">\n*Des crit\u00e8res d\u2019admissibilit\u00e9 suppl\u00e9mentaires s\u2019appliquent\n<\/div>\n<\/div><\/div><div class=\"bde-button-894-202 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify\" target=\"_self\" data-type=\"url\"  aria-label=\"See if you prequalify for the Pulse-1 study.\" >\n\n    \n        <span class=\"button-atom__text\">D\u00e9couvrez si vous vous pr\u00e9qualifiez<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div><div class=\"bde-button-894-203 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--secondary bde-button__button\" href=\"#pulse-qualify-mobile\" target=\"_self\" data-type=\"url\"  aria-label=\"V\u00e9rifiez si vous remplissez les conditions requises pour participer \u00e0 l'\u00e9tude Pulse-1.\" >\n\n    \n        <span class=\"button-atom__text\">D\u00e9couvrez si vous vous pr\u00e9qualifiez<\/span>\n\n        \n        \n                <\/a>\n\n    \n\n\n<\/div>\n<\/div><\/div><\/div>\n<\/section><section id=\"pulse-qualify\" class=\"bde-section-894-204 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-div-894-205 bde-div\">\n  \n  \n\t\n\n\n\n<div class=\"bde-columns-894-206 bde-columns\"><div class=\"bde-column-894-207 bde-column\">\n  \n  \n\t\n\n\n\n\n<\/div><div class=\"bde-column-894-208 bde-column\">\n  \n  \n\t\n\n\n\n<h3 class=\"bde-heading-894-209 bde-heading\">\nD\u00e9couvrez si vous vous pr\u00e9qualifiez\n<\/h3><div class=\"bde-text-894-210 bde-text\">\nR\u00e9pondez \u00e0 quelques questions pour savoir si vous vous pr\u00e9qualifiez pour l\u2019\u00e9tude Pulse-1\nmen\u00e9e chez les personnes pr\u00e9sentant un taux \u00e9lev\u00e9 de triglyc\u00e9rides.\n<\/div><div class=\"bde-rich-text-894-213 bde-rich-text breakdance-rich-text-styles\">\n<p>Pour la pr\u00e9s\u00e9lection de l\u2019\u00e9tude Pulse-1 sur le taux \u00e9lev\u00e9 de C-LDL, <a href=\"https:\/\/vervetrials.com\/prescreener\/?lang=fr\" target=\"_blank\" rel=\"noopener\">cliquez ici.<\/a>.<\/p>\n<\/div><div class=\"bde-rich-text-894-294 bde-rich-text breakdance-rich-text-styles\">\n<p>Vos informations sont stock\u00e9es dans une base de donn\u00e9es conforme \u00e0 la loi HIPAA et fournies aux sites d'essai pour le suivi, le cas \u00e9ch\u00e9ant. Pour plus d'informations, veuillez consulter notre page sur la politique de protection de la vie priv\u00e9e. <a href=\"https:\/\/privacynotice.lilly.com\/global\/\" target=\"_blank\" rel=\"noopener\">veuillez consulter notre page sur la politique de protection de la vie priv\u00e9e<\/a>.<\/p>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/section><section id=\"qualify\" class=\"bde-section-894-214 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><img decoding=\"async\" class=\"bde-image2-894-287 bde-image2\" src=\"https:\/\/pulse1study.com\/wp-content\/uploads\/2025\/01\/pulse-prequalify.jpg\" alt=\"\"><\/div>\n<\/section><section id=\"pulse-qualify-mobile\" class=\"bde-section-894-216 bde-section\">\n              \n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-div-894-217 bde-div\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-218 bde-heading\">\nD\u00e9couvrez si vous vous pr\u00e9qualifiez\n<\/h2><div class=\"bde-text-894-219 bde-text\">\nR\u00e9pondez \u00e0 quelques questions pour savoir si vous vous pr\u00e9qualifiez pour l\u2019\u00e9tude Pulse-1\nmen\u00e9e chez les personnes pr\u00e9sentant un taux \u00e9lev\u00e9 de triglyc\u00e9rides.\n<\/div><div class=\"bde-rich-text-894-222 bde-rich-text breakdance-rich-text-styles\">\n<p>Pour la pr\u00e9s\u00e9lection de l\u2019\u00e9tude Pulse-1 sur le taux \u00e9lev\u00e9 de C-LDL, <a href=\"https:\/\/vervetrials.com\/prescreener\/?lang=fr\" target=\"_blank\" rel=\"noopener\">cliquez ici.<\/a>.<\/p>\n<\/div><div class=\"bde-rich-text-894-295 bde-rich-text breakdance-rich-text-styles\">\nVos informations sont stock\u00e9es dans une base de donn\u00e9es conforme \u00e0 la loi HIPPA et fournies aux sites d'essai pour un suivi le cas \u00e9ch\u00e9ant. Pour plus d'informations, <a href=\"https:\/\/privacynotice.lilly.com\/global\/\" target=\"_blank\">veuillez consulter notre page sur la politique de protection de la vie priv\u00e9e<\/a>.\n<\/div>\n<\/div><\/div>\n<\/section><section id=\"pulse-details\" class=\"bde-section-894-223 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><div class=\"bde-div-894-224 bde-div\">\n  \n  \n\t\n\n\n\n<h2 class=\"bde-heading-894-225 bde-heading\">\nL\u2019\u00e9tude\u00a0Pulse-1 comporte trois\u00a0parties\u00a0:\n<\/h2><div class=\"bde-code-block-894-292 bde-code-block\">\n\n  <style>\n  .study-periods-list {\n    list-style: none;\n    padding: 0 !important;\n    margin: 0 !important;\n  }\n  .study-periods-list > li {\n    display: flex !important;\n    gap: 2rem;\n    align-items: center;\n    border-bottom: 1px solid rgba(0,0,0,0.2);\n    padding: 1.5rem 0 !important;\n    margin: 0 0 1.5rem 0 !important;\n  }\n  .study-periods-list > li:last-child {\n    border-bottom: none;\n    padding-bottom: 0;\n    margin-bottom: 0 !important;\n  }\n  .study-periods__number-1,\n  .study-periods__number-2,\n  .study-periods__number-3 {\n    display: inline-flex;\n    align-items: center;\n    justify-content: center;\n    text-align: center;\n    font-family: \"Prompt\", sans-serif;\n    font-size: 14rem;\n    width: 15%;\n    flex-shrink: 0;\n    align-self: center;\n    line-height: 1 !important;\n  }\n  .study-periods__number-1 { color: #961F8E; }\n  .study-periods__number-2 { color: #11ABE1; }\n  .study-periods__number-3 { color: #8BC344; }\n  .study-periods__content {\n    flex: 1;\n  }\n  .study-periods__title {\n    color: #11ABE1 !important;\n    font-size: 1.5em !important;\n    font-weight: 500 !important;\n    margin-top: 0;\n    margin-bottom: 10px;\n  }\n  .study-periods__duration {\n    margin: 0 0 0.75rem;\n  }\n  .study-periods__body {\n    margin: 0 0 0.75rem;\n  }\n  .study-periods__bullets {\n    padding-left: 2.5rem;\n    margin: 0;\n    list-style-type: disc;\n  }\n  .study-periods__bullets li::marker {\n    color: #000;\n  }\n  @media (max-width: 768px) {\n    .study-periods__number-1,\n    .study-periods__number-2,\n    .study-periods__number-3 {\n      font-size: 6rem;\n      width: 20%;\n    }\n    .study-periods-list > li {\n      gap: 1rem;\n    }\n  }\n  @media (max-width: 480px) {\n    .study-periods__number-1,\n    .study-periods__number-2,\n    .study-periods__number-3 {\n      font-size: 4rem;\n      width: 20%;\n    }\n  }\n<\/style>\n\n<ol class=\"study-periods-list\" style=\"padding:0;\">\n  <li>\n    <div class=\"study-periods__number-1\">1<\/div>\n    <div class=\"study-periods__content\">\n      <h3 class=\"study-periods__title\">P\u00e9riode de s\u00e9lection<\/h3>\n      <p class=\"study-periods__duration\">(jusqu'\u00e0 trois mois)<\/p>\n      <p class=\"study-periods__body\"><strong>Vous vous pr\u00e9senterez \u00e0 des rendez-vous dans le cadre de la s\u00e9lection visant \u00e0 d\u00e9terminer\nvotre admissibilit\u00e9 \u00e0 l\u2019\u00e9tude\u00a0Pulse-1. Plusieurs tests seront r\u00e9alis\u00e9s lors de ces rendez-vous, y\ncompris le pr\u00e9l\u00e8vement d\u2019\u00e9chantillons de sang et la r\u00e9alisation d\u2019examens physiques.<\/strong><\/p>\n      <ul class=\"study-periods__bullets\">\n        <li>Vous aurez deux visites au centre d\u2019\u00e9tude visant \u00e0 d\u00e9terminer si vous \u00eates admissible et\nsi l\u2019\u00e9tude vous convient. Si vous \u00eates admissible, vous aurez la possibilit\u00e9 de participer \u00e0\nl\u2019\u00e9tude.<\/li>\n        <li>Les visites de s\u00e9lection doivent avoir lieu sur une p\u00e9riode de trois mois.<\/li>\n      <\/ul>\n    <\/div>\n  <\/li>\n  <li>\n    <div class=\"study-periods__number-2\">2<\/div>\n    <div class=\"study-periods__content\">\n      <h3 class=\"study-periods__title\">P\u00e9riode de traitement de l'\u00e9tude<\/h3>\n      <p class=\"study-periods__duration\">(jusqu\u2019\u00e0 4\u00a0jours)<\/p>\n      <p class=\"study-periods__body\"><strong>Si vous \u00eates admissible et d\u00e9cidez de participer, la p\u00e9riode de traitement de l\u2019\u00e9tude comprendra\nun s\u00e9jour pouvant aller jusqu\u2019\u00e0 4\u00a0jours\u00a0\/\u00a03\u00a0nuits au centre d\u2019\u00e9tude, au cours duquel\u00a0:<\/strong><\/p>\n      <ul class=\"study-periods__bullets\">\n        <li>Vous recevrez une seule dose de VERVE-201 sous forme de perfusion intraveineuse\n(i.v.) dans une veine de votre bras.<\/li>\n        <li>Pendant votre s\u00e9jour au centre d\u2019\u00e9tude, le personnel de l\u2019\u00e9tude surveillera votre \u00e9tat de\nsant\u00e9 et effectuera des \u00e9valuations semblables \u00e0 celles de la p\u00e9riode de s\u00e9lection, afin\nde v\u00e9rifier votre tol\u00e9rance \u00e0 VERVE-201.<\/li>\n      <\/ul>\n    <\/div>\n  <\/li>\n  <li>\n    <div class=\"study-periods__number-3\">3<\/div>\n    <div class=\"study-periods__content\">\n      <h3 class=\"study-periods__title\">P\u00e9riode de suivi<\/h3>\n      <p class=\"study-periods__duration\">(environ un an)<\/p>\n      <ul class=\"study-periods__bullets\">\n        <li>Il y aura jusqu'\u00e0 11 visites de suivi au cours de l'ann\u00e9e suivant l'administration de VERVE-201 afin de continuer \u00e0 surveiller votre \u00e9tat de sant\u00e9, y compris la visite de fin d'\u00e9tude.<\/li>\n        <li>Apr\u00e8s la visite de fin d\u2019\u00e9tude, vous participerez \u00e0 une \u00e9tude de suivi \u00e0 long terme distincte, au\ncours de laquelle votre sant\u00e9 et vos taux de lipides continueront d\u2019\u00eatre surveill\u00e9s. Certaines de\nces visites peuvent \u00eatre effectu\u00e9es \u00e0 domicile ou au cabinet de votre m\u00e9decin de premier\nrecours local.<\/li>\n      <\/ul>\n    <\/div>\n  <\/li>\n<\/ol>\n\n\n<\/div>\n<\/div><\/div>\n<\/section><section id=\"pulse-locations\" class=\"bde-section-894-251 bde-section\">\n  \n  \n\t\n\n\n\n<div class=\"section-container\"><h2 class=\"bde-heading-894-252 bde-heading\">\nEmplacements des centres d\u2019\u00e9tude\n<\/h2><div class=\"bde-shortcode-894-253 bde-shortcode\"><style>\r\n\t#wpsl-stores .wpsl-store-thumb {height:45px !important; width:45px !important;}\r\n\t#wpsl-stores, #wpsl-direction-details, #wpsl-gmap {height:500px !important;}\r\n\t#wpsl-gmap .wpsl-info-window {max-width:225px !important;}\r\n\t.wpsl-input label, #wpsl-radius label, #wpsl-category label {width:150px;}\r\n\t#wpsl-search-input  {width:179px;}\r\n<\/style>\r\n<div id=\"wpsl-wrap\">\r\n\t<div class=\"wpsl-search wpsl-clearfix\">\r\n\t\t<div id=\"wpsl-search-wrap\">\r\n\t\t\t<form autocomplete=\"off\" action=\"\">\r\n\t\t\t<div class=\"wpsl-input\">\r\n\t\t\t\t<div><label for=\"wpsl-search-input\">Votre emplacement<\/label><\/div>\r\n\t\t\t\t<input id=\"wpsl-search-input\" type=\"text\" value=\"\" name=\"wpsl-search-input\" placeholder=\"\" aria-required=\"true\" \/>\r\n\t\t\t<\/div>\r\n\t\t\t<div class=\"wpsl-select-wrap\">\r\n\t\t\t\t<div id=\"wpsl-radius\">\r\n\t\t\t\t\t<label for=\"wpsl-radius-dropdown\">Rayon de recherche<\/label>\r\n\t\t\t\t\t<select id=\"wpsl-radius-dropdown\" class=\"wpsl-dropdown\" name=\"wpsl-radius\">\r\n\t\t\t\t\t\t<option value=\"10\">10 km<\/option><option value=\"25\">25 km<\/option><option selected=\"selected\" value=\"50\">50 km<\/option><option value=\"100\">100 km<\/option><option value=\"200\">200 km<\/option><option value=\"500\">500 km<\/option>\r\n\t\t\t\t\t<\/select>\r\n\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t\t\t<div class=\"wpsl-search-btn-wrap\"><input id=\"wpsl-search-btn\" type=\"submit\" value=\"Recherche\"><\/div>\r\n\t\t<input type=\"hidden\" name=\"trp-form-language\" value=\"fr\"\/><\/form>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\t<div id=\"wpsl-gmap\" class=\"wpsl-gmap-canvas\"><\/div>\r\n\t<div id=\"wpsl-result-list\">\r\n\t\t<div id=\"wpsl-stores\" >\r\n\t\t\t<ul><\/ul>\r\n\t\t<\/div>\r\n\t\t<div id=\"wpsl-direction-details\">\r\n\t\t\t<ul><\/ul>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<\/div><div class=\"bde-button-894-254 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-qualify\" target=\"_self\" data-type=\"url\"  aria-label=\"See if you prequalify for the Pulse-1 study.\" >\n\n    \n        <span class=\"button-atom__text\">D\u00e9couvrez si vous vous pr\u00e9qualifiez<\/span>\n\n                            \n        \n                <\/a>\n\n    \n\n\n<\/div><div class=\"bde-button-894-255 bde-button\">\n        \n    \n    \n    \n                            \n            \n                    \n            \n            \n\n    \n    \n    \n    \n                            \n    <a class=\"breakdance-link button-atom button-atom--custom bde-button__button\" href=\"#pulse-qualify-mobile\" target=\"_self\" data-type=\"url\"  aria-label=\"V\u00e9rifiez si vous remplissez les conditions requises pour participer \u00e0 l'\u00e9tude Pulse-1.\" >\n\n    \n        <span class=\"button-atom__text\">D\u00e9couvrez si vous vous pr\u00e9qualifiez<\/span>\n\n                            \n        \n                <\/a>\n\n    \n\n\n<\/div><\/div>\n<\/section><\/main>","protected":false},"excerpt":{"rendered":"<p>Help shape the future of high triglyceride treatment Be part of the Pulse-1 study The Pulse-1 study is an ongoing clinical trial enrolling people who have severe hypertriglyceridemia, a condition that involves higher than normal levels of triglycerides in the blood. Triglyceride levels that are too high can cause pancreatitis and may increase the risk [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"_breakdance_hide_in_design_set":false,"_breakdance_tags":"","footnotes":""},"class_list":["post-894","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/pages\/894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/comments?post=894"}],"version-history":[{"count":73,"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/pages\/894\/revisions"}],"predecessor-version":[{"id":1332,"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/pages\/894\/revisions\/1332"}],"wp:attachment":[{"href":"https:\/\/hightg.vervetrials.com\/fr\/wp-json\/wp\/v2\/media?parent=894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}